Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Nov. 25, 2020, 2:57 p.m. EST

Biochemical analysis company 908 Devices files to go public

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Renaissance IPO ETF (IPO)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

908 Devices Inc., a Boston-based biochemical analysis company, has filed to go public on the Nasdaq, under the ticker symbol "MASS." The company has not yet determined the number of shares to offer in the initial public offering or the expected pricing range. Cowen, SVB Leerink, William Blair and Stifel are the joint book-running managers. That company, which makes handheld and desktop spectrometry instruments, recorded a net loss of $2.7 million on revenue of $21.2 million over the nine months ended Sept. 30, after a loss of $13.0 million on revenue of $9.6 million in the same period a year ago. The company is looking to go public at a time of healthy investor demand for IPOs, as the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO +0.42% has soared 31.0% over the past three months while the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.21% has gained 5.4%.

/zigman2/quotes/207665280/composite
US : U.S.: NYSE Arca
$ 69.98
+0.29 +0.42%
Volume: 204,203
Jan. 21, 2021 2:59p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,859.87
+8.02 +0.21%
Volume: 1.73B
Jan. 21, 2021 2:59p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.